title: Antibiotics--an investment worth making?
abstract: Antibiotics markets are huge and the need for new classes of antibiotics is great, but the risks give investors pause.
authors.affiliation: Morgenthaler Ventures, 4430 Arapahoe Avenue, Suite 220, Boulder, Colorado 80303, USA. rchris@morgenthaler.com
authors.forename: Ralph E
authors.initials: RE
authors.lastname: Christoffersen
mesh_terms: D000900:Anti-Bacterial Agents / Q000191:economics* / Q000302:isolation & purification; D017277:Drug Approval / Q000191:economics / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000191:economics*; D016568:Drugs, Generic / Q000191:economics*; D007449:Investments / Q000191:economics*; D014481:United States
chemical_list: D000900:Anti-Bacterial Agents; D016568:Drugs, Generic